APOE and Alzheimer disease: The LCD showed better memory performance and was positively correlated with levels of KBs.182 Krikorian et al. reported maximum cognitive benefit of KD treatment in ApoE4(−) patients after 24-week treatment with MCT or a ketogenic product compared to placebo.183 This observational study was limited to ApoE4(−) patients with mild AD.